Paraskevi Boura

Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients

Eleni Karapanagiotou, Aristidis Polyzos, Kalliopi Dilana et al. · Lung Cancer · 2009 · 50 citations

Obesity, Metabolic Syndrome, Medicine +5

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study

Konstantinos Syrigos, Dimitra Grapsa, Rabiatou Sangare et al. · The Oncologist · 2018 · 49 citations · Full text

Hypersensitivity Reactions to Oxaliplatin: A Retrospective Study and the Development of a Desensitization Protocol

Ekaterini Syrigou, Eleni Karapanagiotou, Christina Alamara et al. · Clinical Colorectal Cancer · 2009 · 38 citations

Retrospective Study, Drug Hypersensitivity, Allergy +11

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Ioannis Vathiotis, Evangelos Dimakakos, Paraskevi Boura et al. · Clinical and Applied Thrombosis/Hemostasis · 2018 · 31 citations · Full text

Lung Adenocarcinoma, Prognosis, Adjuvant Chemotherapy +17

Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.

Eleni Karapanagiotou, Paraskevi Boura, George Papamichalis et al. · PubMed · 2009 · 16 citations

Progression-free Survival, Surgical Oncology, Medicine +13